136 related articles for article (PubMed ID: 32341351)
1. Decreased ZNF750 promotes angiogenesis in a paracrine manner via activating DANCR/miR-4707-3p/FOXC2 axis in esophageal squamous cell carcinoma.
Bi Y; Guo S; Xu X; Kong P; Cui H; Yan T; Ma Y; Cheng Y; Chen Y; Liu X; Zhang L; Cheng C; Xu E; Qian Y; Yang J; Song B; Li H; Wang F; Hu X; Liu X; Niu X; Zhai Y; Liu J; Li Y; Cheng X; Cui Y
Cell Death Dis; 2020 Apr; 11(4):296. PubMed ID: 32341351
[TBL] [Abstract][Full Text] [Related]
2. Novel ESCC-related gene ZNF750 as potential Prognostic biomarker and inhibits Epithelial-Mesenchymal Transition through directly depressing SNAI1 promoter in ESCC.
Kong P; Xu E; Bi Y; Xu X; Liu X; Song B; Zhang L; Cheng C; Yan T; Qian Y; Yang J; Ma Y; Cui H; Zhai Y; Zou B; Liu X; Cheng Y; Guo S; Cheng X; Cui Y
Theranostics; 2020; 10(4):1798-1813. PubMed ID: 32042337
[No Abstract] [Full Text] [Related]
3. ZNF750 Expression Is a Potential Prognostic Biomarker in Esophageal Squamous Cell Carcinoma.
Otsuka R; Akutsu Y; Sakata H; Hanari N; Murakami K; Kano M; Toyozumi T; Takahashi M; Matsumoto Y; Sekino N; Yokoyama M; Okada K; Shiraishi T; Komatsu A; Iida K; Matsubara H
Oncology; 2018; 94(3):142-148. PubMed ID: 29216641
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-33a-5p suppresses esophageal squamous cell carcinoma progression via regulation of lncRNA DANCR and ZEB1.
Zhang C; Wang L; Yang J; Fu Y; Li H; Xie L; Cui Y
Eur J Pharmacol; 2019 Oct; 861():172590. PubMed ID: 31401160
[TBL] [Abstract][Full Text] [Related]
5. Potential Role of Targeting KDR and Proteasome Inhibitors in the Therapy of Esophageal Squamous Cell Carcinoma.
Zhang L; Niu X; Bi Y; Cui H; Li H; Cheng X
Technol Cancer Res Treat; 2020; 19():1533033820948060. PubMed ID: 32924793
[TBL] [Abstract][Full Text] [Related]
6. Whole-exome sequencing reveals critical genes underlying metastasis in oesophageal squamous cell carcinoma.
Dai W; Ko JMY; Choi SSA; Yu Z; Ning L; Zheng H; Gopalan V; Chan KT; Lee NP; Chan KW; Law SY; Lam AK; Lung ML
J Pathol; 2017 Aug; 242(4):500-510. PubMed ID: 28608921
[TBL] [Abstract][Full Text] [Related]
7. Circular RNA circNTRK2 facilitates the progression of esophageal squamous cell carcinoma through up-regulating NRIP1 expression via miR-140-3p.
Chen X; Jiang J; Zhao Y; Wang X; Zhang C; Zhuan L; Zhang D; Zheng Y
J Exp Clin Cancer Res; 2020 Jul; 39(1):133. PubMed ID: 32653032
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA ESCCAL-1 promotes esophageal squamous cell carcinoma by down regulating the negative regulator of APOBEC3G.
Liu J; Mayekar MK; Wu W; Yan M; Guan H; Wang J; Zaman A; Cui Y; Bivona TG; Choudhry H; Xing Q; Cao W
Cancer Lett; 2020 Nov; 493():217-227. PubMed ID: 32905814
[TBL] [Abstract][Full Text] [Related]
9. Promoter hypomethylation mediated upregulation of MicroRNA-10b-3p targets FOXO3 to promote the progression of esophageal squamous cell carcinoma (ESCC).
Lu YF; Yu JR; Yang Z; Zhu GX; Gao P; Wang H; Chen SY; Zhang J; Liu MY; Niu Y; Wei XM; Wang W; Ye FJ; Zhang LX; Zhao Y; Sun GG
J Exp Clin Cancer Res; 2018 Dec; 37(1):301. PubMed ID: 30514328
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-153-3p regulates cell proliferation and cisplatin resistance via Nrf-2 in esophageal squamous cell carcinoma.
Zuo J; Zhao M; Fan Z; Liu B; Wang Y; Li Y; Lv P; Xing L; Zhang X; Shen H
Thorac Cancer; 2020 Mar; 11(3):738-747. PubMed ID: 32012470
[TBL] [Abstract][Full Text] [Related]
11. LINC00657 played oncogenic roles in esophageal squamous cell carcinoma by targeting miR-615-3p and JunB.
Sun Y; Wang J; Pan S; Yang T; Sun X; Wang Y; Shi X; Zhao X; Guo J; Zhang X
Biomed Pharmacother; 2018 Dec; 108():316-324. PubMed ID: 30227324
[TBL] [Abstract][Full Text] [Related]
12. [Function and mechanism of zinc finger protein ZNF50 in inhibiting the growth of esophageal squamous cell carcinoma cells].
Wang J; Bi YH; Yang J; Liu F; Li YK; Cui HY; Wang F; Liu J; Yang B; Zhang L
Zhonghua Zhong Liu Za Zhi; 2017 Jan; 39(1):7-12. PubMed ID: 28104026
[No Abstract] [Full Text] [Related]
13. Intratumoral heterogeneity of esophageal squamous cell carcinoma and its clinical significance.
Wang X; Jia Y; Deng H; Liu Y; Liu Y
Pathol Res Pract; 2019 Feb; 215(2):308-314. PubMed ID: 30528923
[TBL] [Abstract][Full Text] [Related]
14. ZNF750 Expression as a Novel Candidate Biomarker of Chemoradiosensitivity in Esophageal Squamous Cell Carcinoma.
Otsuka R; Akutsu Y; Sakata H; Hanari N; Murakami K; Kano M; Takahashi M; Matsumoto Y; Sekino N; Yokoyama M; Iida K; Matsubara H
Oncology; 2017; 93(3):197-203. PubMed ID: 28558382
[TBL] [Abstract][Full Text] [Related]
15. microRNA-messenger RNA regulatory network of esophageal squamous cell carcinoma and the identification of miR-1 as a biomarker of patient survival.
Wei Q; Li X; Yu W; Zhao K; Qin G; Chen H; Gu Y; Ding F; Zhu Z; Fu X; Sun M
J Cell Biochem; 2019 Aug; 120(8):12259-12272. PubMed ID: 31017699
[TBL] [Abstract][Full Text] [Related]
16. Functional Role of a Novel Long Noncoding RNA
Lin C; Zhang S; Wang Y; Wang Y; Nice E; Guo C; Zhang E; Yu L; Li M; Liu C; Hu L; Hao J; Qi W; Xu H
Clin Cancer Res; 2018 Jan; 24(2):486-498. PubMed ID: 29101304
[No Abstract] [Full Text] [Related]
17. LncRNA TUG1 contributes to ESCC progression via regulating miR-148a-3p/MCL-1/Wnt/β-catenin axis in vitro.
Tang Y; Yang P; Zhu Y; Su Y
Thorac Cancer; 2020 Jan; 11(1):82-94. PubMed ID: 31742924
[TBL] [Abstract][Full Text] [Related]
18. lncRNA MIAT promotes esophageal squamous cell carcinoma progression by regulating miR-1301-3p/INCENP axis and interacting with SOX2.
Zhang C; Xie L; Fu Y; Yang J; Cui Y
J Cell Physiol; 2020 Nov; 235(11):7933-7944. PubMed ID: 31943174
[TBL] [Abstract][Full Text] [Related]
19. lncTUG1/miR-144-3p affect the radiosensitivity of esophageal squamous cell carcinoma by competitively regulating c-MET.
Wang P; Yang Z; Ye T; Shao F; Li J; Sun N; He J
J Exp Clin Cancer Res; 2020 Jan; 39(1):7. PubMed ID: 31918742
[TBL] [Abstract][Full Text] [Related]
20. LINC00152 facilitates tumorigenesis in esophageal squamous cell carcinoma via miR-153-3p/FYN axis.
Liu D; Gao M; Wu K; Zhu D; Yang Y; Zhao S
Biomed Pharmacother; 2019 Apr; 112():108654. PubMed ID: 30784933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
